Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;36(2):170-3.
doi: 10.4103/0253-7176.130986.

Olanzapine discontinuation emergent recurrence in bipolar disorder

Manu Arora  1 , Samir Kumar Praharaj  2
Affiliations

Olanzapine discontinuation emergent recurrence in bipolar disorder

Manu Arora et al. Indian J Psychol Med. 2014 Apr.

Abstract

Objective: The efficacy of atypical antipsychotics including olanzapine in acute treatment of manic episode has been established, whereas its role in maintenance treatment is not clear.

Materials and methods: Thirteen patients of bipolar disorder who were on regular treatment with mood stabilizer and subsequently relapsed into mania or depressive episode after discontinuation of olanzapine were studied for various socio-demographic and clinical factors using retrospective chart review.

Results: There was no correlation found between the period of tapering olanzapine, time to recurrence of episode after discontinuation, and the dosage of olanzapine at the time of discontinuation. The predominant early signs of relapse after discontinuation of olanzapine included sleep disturbance (72.7%), lack of insight for change in behavior (72.7%), irritability (54.5%), and elevated mood (45.5%).

Conclusion: Mood stabilizer alone as a maintenance therapy of bipolar disorder may be inadequate for long-term management. A low dose of olanzapine along with mood stabilizers might be useful for prevention of recurrence in bipolar disorder.

Keywords: Bipolar disorder; depression; mania; olanzapine; recurrence.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

Similar articles

See all similar articles

References

    1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision) Am J Psychiatry. 2002;159(Suppl 4):1–50. - PubMed
    1. Baldessarini RJ, Tondo L. Does lithium treatment still work? Evidence of stable response over three decades. Arch Gen Psychiatry. 2000;57:187–90. - PubMed
    1. Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: A 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry. 1998;155:30–5. - PubMed
    1. Kane JM, Smith JM. Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry. 1982;39:473–81. - PubMed
    1. Zarate CA, Jr, Tohen M. Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Am J Psychiatry. 2004;161:169–71. - PubMed

LinkOut - more resources